Acorda Therapeutics reported $0 in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 0M 236.9M
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
ALKERMES ALKS:US $ 297.07M 0.63M
Amgen AMGN:US $ 32782M 97M
Anika Therapeutics ANIK:US $ 0M 0.12M
Aptinyx Inc APTX:US $ 0 0
Arrowhead Research ARWR:US $ 0M 0M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Cara Therapeutics CARA:US $ 0 0
Clovis Oncology CLVS:US $ 64.35M 564.25M
Cytokinetics CYTK:US $ 139.14M 1.75M
GlaxoSmithKline GSK:LN 25483M 736M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Halozyme Therapeutics HALO:US $ 874.74M 0.96M
Heron Therapeutics HRTX:US $ 148.98M 141.43M
Insmed INSM:US $ 564.02M 186.91M
Ligand Pharmaceuticals LGND:US $ 315.36M 42.39M
Mannkind MNKD:US $ 285.13M 45.46M
Merck MRK:GR € 11999M 349M
Moderna Inc MRNA:US 487M 304M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Novartis NOVN:VX SF 35769M 2030M
Teva Pharmaceutical TEVA:IT 25.13B 147M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M